Reducing Cesarean Sections for Difficult Labors
The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia
This study is testing new guidelines to see if they can help first-time mothers have safer labors and reduce the number of cesarean sections needed.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100000 (estimated) |
| Sex | Female |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Trial ID | NCT02874443 on ClinicalTrials.gov |
What this trial studies
This project is a clustered randomized controlled trial aimed at implementing new ACOG guidelines to improve the diagnosis of poor progress in labor. The goal is to reduce cesarean section rates among first-time mothers at term with a singleton fetus while ensuring maternal and neonatal safety. The intervention will be rolled out in Alberta hospitals that meet specific criteria, with randomization occurring at the center level to prevent crossover effects. The study will involve a sequential introduction of the intervention across different hospital strata over a multi-week period.
Who should consider this trial
Good fit: Ideal candidates for this study are first-time mothers at term with a singleton fetus who are experiencing labor difficulties.
Not a fit: Patients who are not first-time mothers or those with multiple gestations may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly lower the rates of unnecessary cesarean sections, improving outcomes for mothers and babies.
How similar studies have performed: Other studies have shown success in implementing similar knowledge translation interventions to reduce cesarean section rates, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Centers in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually Exclusion Criteria:
Where this trial is running
Calgary, Alberta
- University of Calgary — Calgary, Alberta, Canada (Recruiting)
Study contacts
- Principal investigator: Stephen Wood, MD MSc — University of Calgary
- Study coordinator: Stephen Wood, MD MSc
- Email: slwood@ucalgary.ca
- Phone: 403-9441438
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.